tamsulosin has been researched along with Urination Disorders in 75 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (5.33) | 18.2507 |
2000's | 50 (66.67) | 29.6817 |
2010's | 21 (28.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gyaurgiev, TA; Kuzmenko, AV; Kuzmenko, VV | 1 |
Ergakov, DV; Martov, AG | 1 |
Angulo, JC; Garcia-Hernandez, A; Haab, F; Katona, F; Klaver, M; Oelke, M; Traudtner, K; Van Kerrebroeck, P; Vik, V | 2 |
Apostolidis, A | 1 |
Conti, A; Fontana, D; Mattia, M; Milanese, G; Minardi, D; Muzzonigro, G; Pellegrinelli, F | 1 |
Andersson, KE | 1 |
Chang, SJ; Chiang, IN; Yu, HJ | 1 |
Bavendam, T; Guan, Z; Kaplan, SA; Kraus, SR; Roehrborn, CG; Wang, JT | 1 |
Gitlin, J; Palmer, LS; Toro, S; Vanderbrink, BA | 1 |
Fujihara, A; Kamoi, K; Kanazawa, M; Miki, T; Okihara, K; Ukimura, O | 1 |
Furuya, R; Iwasawa, A; Masumori, N; Mori, M; Sonoda, T; Tsukamoto, T | 1 |
Chang, CH; Huang, SW; Wang, CJ | 1 |
Chang, SJ; Yang, SS | 1 |
Combs, AJ; Glassberg, KI; Horowitz, M; Van Batavia, JP | 1 |
Choo, MS; Han, DH; Jeong, H; Kim, H; Lee, KS; Lee, SJ; Lee, YS; Park, HJ; Park, WH; Yoo, TK; Yoon, H | 1 |
Hisamatsu, H; Yamashita, S | 1 |
Fujii, N; Miyakita, H; Onodera, Y; Tojo, T; Tokunaga, M; Utsunomiya, T; Yanada, S; Yokoyama, E | 1 |
Gravas, S | 1 |
Andriole, GL; Castro, R; Rittmaster, RS; Roehrborn, CG; Wilson, TH | 1 |
Chapple, CR; Fernández Fernández, E; Koldewijn, E; Montorsi, F; Tammela, TL; Wirth, M | 1 |
Mullen, K | 1 |
Fujii, T; Fukumoto, K; Hara, R; Jo, Y; Miyaji, Y; Nagai, A; Sone, A; Yokoyama, T | 1 |
Dargallo, T; Gómez Veiras, JR; González, M; Molina Vázquez, ME; Pais, E; Palacios, MG; Somoza Arguibay, I; Tellado, M; Vela, D | 1 |
Jin, J; Wan, B; Wang, X; Yang, Y; Ye, H; Yu, W; Zhang, K; Zhang, N; Zhong, C | 1 |
Ding, H; Gao, M; Li, Q; Lu, J; Wang, H; Wang, Z; Zhong, G | 1 |
Ahn, S; Jang, JH; Kang, SB; Kim, DW; Lee, SM; Park, JS | 1 |
Brown, JN; Meyer, LE | 1 |
Horita, H; Masumori, N; Miyao, N; Sato, E; Sunaoshi, K; Takeyama, K; Tanaka, Y; Tsukamoto, T | 1 |
Demyttenaere, K; Huygens, R | 1 |
Butler, WM; Galbreath, RW; Lief, JH; Merrick, GS; Wallner, KE | 1 |
Koraev, KN | 1 |
Arai, Y; Ichioka, K; Matsui, Y; Ohara, H; Terada, N; Terai, A; Yoshimura, K | 1 |
Evans, CP; Moon, T; Narayan, P | 1 |
Schulman, CC | 1 |
Ameda, K; Kakizaki, H; Kobayashi, S; Koyanagi, T; Shibata, T; Tanaka, H | 1 |
Abe, K; Goto, H; Ikemoto, I; Kishimoto, K; Kiyota, H; Miki, K; Ohishi, Y | 1 |
Brausi, M; Porru, D; Rigatti, P; Rizzi, CA; Scarpa, RM; Schumacher, H | 1 |
Akbay, E; Bozlu, M; Canpolat, B; Cayan, S; Doruk, E; Schellhammer, PF; Ulusoy, E | 1 |
Barqawi, A; Crawford, ED; Gamito, E; O'Donnell, C | 1 |
Efimenko, NA; Shaplygin, LV | 1 |
Barnett, G; Brown, CT; Ellis, BW; Emberton, M; Ryan, M; Watson, V | 1 |
Erduran, D; Goktas, S; Kibar, Y; Kilic, S; Yanardag, H | 1 |
Combs, AJ; Donohoe, JM; Glassberg, KI | 1 |
Allen, Z; Butler, WM; Galbreath, RW; Lief, JH; Merrick, GS; Wallner, KE | 1 |
Akbay, E; Bozlu, M; Cayan, S; Görür, S; Ulusoy, E | 1 |
Nordling, J | 1 |
Altman, A; Angermeier, KW; Chehade, N; Ciezki, JP; Elshaikh, MA; Klein, EA; Reddy, CA; Ulchaker, JC | 1 |
Muzzonigro, G | 1 |
Miyata, K | 1 |
Coban, H; Goktas, S; Kibar, Y; Kilic, S; Seckin, B; Topac, H | 1 |
Burnett, AL; Wein, AJ | 1 |
Deguchi, T; Ishihara, S; Masue, T; Miwa, K; Nishino, Y; Takahashi, Y | 1 |
Kobayashi, M; Morita, T; Tokue, A | 1 |
Aslan, G; Esen, A; Koseoglu, H; Ozdemir, I | 1 |
Höfner, K; Michel, MC; Pfeiffer, N | 1 |
Hosokawa, Y; Kishino, T; Momose, H; Ono, T; Oyama, N | 1 |
Kochakarn, W; Pummangura, N | 1 |
Ku, JH; Song, YS | 1 |
Abrams, P; Barendrecht, MM; de la Rosette, JJ; Michel, MC; Schumacher, H | 1 |
Shaplygin, LV | 1 |
Barkin, J; Damião, R; Major-Walker, K; Montorsi, F; Morrill, B; Roehrborn, CG; Siami, P | 1 |
Hirayama, H; Ishimatsu, T; Ogata, I; Seo, H; Tsuruda, A; Tsuzaki, S; Yamasaki, K | 1 |
Autorino, R; D'Armiento, M; Damiano, R; De Sio, M; Giacobbe, A; Palumbo, IM | 1 |
Asano, M; Fujikura, T; Honda, K; Niigata, K; Takenaka, T | 1 |
Fujita, K; Kawabe, K; Kurita, Y; Masuda, H; Suzuki, K | 1 |
Basharkhah, A; Bursa, B; Djavan, B; Ghawidel, K; Hruby, S; Marberger, M | 1 |
Lee, TH | 1 |
Fujioka, T; Goto, Y; Isurugi, K; Katoh, T; Numasato, S; Obara, W; Omori, S; Suzuki, Y | 1 |
Cervenakov, I; Fillo, J | 1 |
Boeminghaus, F; Buzelin, JM; Lock, TM; Schulman, CC; Stephenson, TP; Talja, M | 1 |
Demyttenaere, K; Huygens, R; Van Buggenhout, R | 1 |
MacDonald, R; Nelson, D; Wilt, TJ | 1 |
Aoki, A; Baba, Y; Hara, Y; Harada, H; Harada, N; Hashimoto, O; Hayashida, S; Hirao, H; Hironaka, H; Isoyama, R; Jojima, K; Joko, K; Kamiryo, Y; Kato, M; Koshido, Y; Matsuyama, H; Mitsui, H; Nagao, K; Nagata, K; Naito, K; Nasu, T; Otsuka, T; Sacho, T; Shimizu, Y; Shiraishi, K; Suyama, K; Takemoto, M; Tuchida, M; Wada, T; Yamaguchi, M; Yamakawa, G | 1 |
6 review(s) available for tamsulosin and Urination Disorders
Article | Year |
---|---|
Tamsulosin for voiding dysfunction in women.
Topics: Adrenergic alpha-1 Receptor Antagonists; Female; Humans; Lower Urinary Tract Symptoms; Sulfonamides; Tamsulosin; Urination Disorders | 2012 |
Lower urinary tract symptoms/benign prostatic hyperplasia: minimizing morbidity caused by treatment.
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Aged; Blood Pressure; Drug Therapy, Combination; Ejaculation; Erectile Dysfunction; Humans; Male; Phytotherapy; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urination Disorders | 2003 |
[Drug discovery in the fields of urology: tamsulosin and solifenacin].
Topics: Adrenergic alpha-Antagonists; Animals; Biological Availability; Cholinergic Antagonists; Delayed-Action Preparations; Drug Design; Humans; Male; Quinuclidines; Receptor, Muscarinic M3; Solifenacin Succinate; Sulfonamides; Tamsulosin; Tetrahydroisoquinolines; Urinary Bladder; Urination Disorders | 2005 |
Benign prostatic hyperplasia in primary care: what you need to know.
Topics: Age Distribution; Aged; Aged, 80 and over; Benzhydryl Compounds; Biopsy, Needle; Cresols; Humans; Immunohistochemistry; Incidence; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prognosis; Prostatic Hyperplasia; Risk Assessment; Severity of Illness Index; Sulfonamides; Tamsulosin; Tolterodine Tartrate; Transurethral Resection of Prostate; Treatment Outcome; Urinary Bladder Neck Obstruction; Urination Disorders | 2006 |
[Discovery and development of tamsulosin hydrochloride, a new alpha 1-adrenoceptor antagonist].
Topics: Adrenergic alpha-Antagonists; Animals; Clinical Trials as Topic; Humans; Male; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urination Disorders | 1995 |
Tamsulosin for treating lower urinary tract symptoms compatible with benign prostatic obstruction: a systematic review of efficacy and adverse effects.
Topics: Adrenergic alpha-Antagonists; Humans; Male; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Quality of Life; Randomized Controlled Trials as Topic; Sulfonamides; Tamsulosin; Urination Disorders; Urodynamics | 2002 |
39 trial(s) available for tamsulosin and Urination Disorders
Article | Year |
---|---|
[Combination drug therapy in patients with BPH].
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-1 Receptor Antagonists; Aged; Drug Combinations; Dutasteride; Humans; Male; Middle Aged; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin; Treatment Outcome; Urination Disorders | 2018 |
[Combination therapy in the management of urinary disorders after transurethral resection of the prostate].
Topics: Drug Combinations; Humans; Male; Prostatic Hyperplasia; Quality of Life; Solifenacin Succinate; Sulfonamides; Tamsulosin; Transurethral Resection of Prostate; Treatment Outcome; Urination Disorders; Urological Agents | 2018 |
Efficacy and safety of solifenacin plus tamsulosin OCAS in men with voiding and storage lower urinary tract symptoms: results from a phase 2, dose-finding study (SATURN).
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Dose-Response Relationship, Drug; Double-Blind Method; Drug Dosage Calculations; Drug Therapy, Combination; Europe; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Muscarinic Antagonists; Quality of Life; Quinuclidines; Solifenacin Succinate; Sulfonamides; Tamsulosin; Tetrahydroisoquinolines; Time Factors; Treatment Outcome; Urinary Bladder; Urination; Urination Disorders; Urodynamics; Urological Agents | 2013 |
α1-Blockers for the treatment of recurrent urinary tract infections in women with dysfunctional voiding: a prospective randomized study.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Aged; Female; Follow-Up Studies; Humans; Middle Aged; Prospective Studies; Quality of Life; Sulfonamides; Tamsulosin; Urinary Tract Infections; Urination Disorders; Urodynamics | 2015 |
The effectiveness of tamsulosin in treating women with voiding difficulty.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Female; Humans; Middle Aged; Prospective Studies; Sulfonamides; Tamsulosin; Treatment Outcome; Urination Disorders; Young Adult | 2008 |
Effects of serum PSA on efficacy of tolterodine extended release with or without tamsulosin in men with LUTS, including OAB.
Topics: Adrenergic alpha-Antagonists; Aged; Benzhydryl Compounds; Cohort Studies; Cresols; Delayed-Action Preparations; Drug Therapy, Combination; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Predictive Value of Tests; Prostate-Specific Antigen; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urination Disorders | 2008 |
Naftopidil versus tamsulosin hydrochloride for lower urinary tract symptoms associated with benign prostatic hyperplasia with special reference to the storage symptom: a prospective randomized controlled study.
Topics: Adrenergic alpha-Antagonists; Aged; Humans; Male; Middle Aged; Naphthalenes; Piperazines; Prospective Studies; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urination Disorders | 2008 |
Ejaculatory disorders caused by alpha-1 blockers for patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: comparison of naftopidil and tamsulosin in a randomized multicenter study.
Topics: Adrenergic alpha-Antagonists; Aged; Ejaculation; Humans; Male; Middle Aged; Naphthalenes; Piperazines; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urination Disorders | 2009 |
Effects of tamsulosin on lower urinary tract symptoms due to double-J stent: a prospective study.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Female; Flank Pain; Humans; Male; Middle Aged; Quality of Life; Stents; Sulfonamides; Tamsulosin; Ureter; Ureteral Calculi; Urination Disorders | 2009 |
Efficacy and safety of tamsulosin for the treatment of non-neurogenic voiding dysfunction in females: a 8-week prospective study.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Female; Humans; Middle Aged; Severity of Illness Index; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Treatment Outcome; Urination Disorders | 2010 |
Short-term effects of crossover treatment with silodosin and tamsulosin hydrochloride for lower urinary tract symptoms associated with benign prostatic hyperplasia.
Topics: Adrenergic alpha-Antagonists; Aged; Cross-Over Studies; Humans; Indoles; Male; Middle Aged; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin; Treatment Outcome; Urinary Tract; Urination Disorders | 2010 |
Effect of dutasteride on prostate biopsy rates and the diagnosis of prostate cancer in men with lower urinary tract symptoms and enlarged prostates in the Combination of Avodart and Tamsulosin trial.
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-1 Receptor Antagonists; Aged; Azasteroids; Biopsy; Drug Therapy, Combination; Dutasteride; Humans; Incidence; Male; Middle Aged; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Risk Factors; Sulfonamides; Tamsulosin; Urination Disorders | 2011 |
Silodosin therapy for lower urinary tract symptoms in men with suspected benign prostatic hyperplasia: results of an international, randomized, double-blind, placebo- and active-controlled clinical trial performed in Europe.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Double-Blind Method; Europe; Humans; Indoles; Male; Middle Aged; Nocturia; Placebo Effect; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin; Treatment Outcome; Urination; Urination Disorders | 2011 |
Effects of three types of alpha-1 adrenoceptor blocker on lower urinary tract symptoms and sexual function in males with benign prostatic hyperplasia.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Ejaculation; Erectile Dysfunction; Humans; Indoles; Male; Middle Aged; Naphthalenes; Patient Satisfaction; Piperazines; Prostatic Hyperplasia; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Urination; Urination Disorders | 2011 |
Effect of doxazosin gastrointestinal therapeutic system 4 mg vs tamsulosin 0.2 mg on nocturia in Chinese men with lower urinary tract symptoms: a prospective, multicenter, randomized, open, parallel study.
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Doxazosin; Humans; Male; Middle Aged; Nocturia; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urination Disorders | 2011 |
The effects of transrectal radiofrequency hyperthermia on patients with chronic prostatitis and the changes of MDA, NO, SOD, and Zn levels in pretreatment and posttreatment.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Anti-Bacterial Agents; Body Fluids; Chronic Disease; Clarithromycin; Combined Modality Therapy; Diathermy; Humans; Male; Malondialdehyde; Nitric Oxide; Pelvic Pain; Prostatitis; Quality of Life; Radiofrequency Therapy; Semen; Sulfonamides; Superoxide Dismutase; Tamsulosin; Urination Disorders; Zinc | 2012 |
Randomized controlled trial of tamsulosin for prevention of acute voiding difficulty after rectal cancer surgery.
Topics: Adrenergic alpha-1 Receptor Antagonists; Female; Humans; Male; Middle Aged; Postoperative Complications; Rectal Neoplasms; Sulfonamides; Tamsulosin; Urination Disorders | 2012 |
α1-blocker tamsulosin as initial treatment for patients with benign prostatic hyperplasia: 5-year outcome analysis of a prospective multicenter study.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Disease Progression; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Patient Dropouts; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome; Urinary Retention; Urination Disorders | 2013 |
Prophylactic versus therapeutic alpha-blockers after permanent prostate brachytherapy.
Topics: Adenocarcinoma; Adrenergic alpha-Antagonists; Biopsy; Brachytherapy; Doxazosin; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Palladium; Postoperative Complications; Prazosin; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radiotherapy, Conformal; Sulfonamides; Tamsulosin; Treatment Outcome; Urinary Retention; Urination Disorders | 2002 |
Long-term safety and efficacy of tamsulosin for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia.
Topics: Adrenergic alpha-Antagonists; Humans; Male; Middle Aged; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urination Disorders; Urodynamics | 2003 |
Urodynamic effects of alpha1-blocker tamsulosin on voiding dysfunction in patients with neurogenic bladder.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Female; Humans; Male; Middle Aged; Muscle Contraction; Pressure; Sex Factors; Sulfonamides; Tamsulosin; Treatment Outcome; Urinary Bladder, Neurogenic; Urination Disorders; Urodynamics | 2003 |
Usefulness of tamsulosin hydrochloride and naftopidil in patients with urinary disturbances caused by benign prostatic hyperplasia: a comparative, randomized, two-drug crossover study.
Topics: Adrenergic alpha-Antagonists; Aged; Cross-Over Studies; Dizziness; Headache; Humans; Hypotension, Orthostatic; Male; Middle Aged; Naphthalenes; Patient Satisfaction; Piperazines; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin; Treatment Outcome; Urination Disorders | 2003 |
A comparison of the efficacy and tolerability of tamsulosin and finasteride in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Finasteride; Humans; Male; Middle Aged; Prostatic Hyperplasia; Sexual Behavior; Sulfonamides; Tamsulosin; Urination Disorders | 2003 |
[The prophylaxis and treatment of urination disorders in the early postoperative period].
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Drug Administration Schedule; Humans; Male; Postoperative Care; Postoperative Complications; Sulfonamides; Tamsulosin; Time Factors; Treatment Outcome; Urinary Catheterization; Urination Disorders; Wounds and Injuries | 2004 |
Intermittent tamsulosin therapy in men with lower urinary tract symptoms.
Topics: Adrenergic alpha-Antagonists; Half-Life; Humans; Middle Aged; Prospective Studies; Sulfonamides; Tamsulosin; Urination Disorders; Urodynamics | 2005 |
Brachytherapy-related dysuria.
Topics: Adrenergic alpha-Antagonists; Aged; Antineoplastic Agents; Brachytherapy; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Prostatic Neoplasms; Quality of Life; Severity of Illness Index; Sulfonamides; Tamsulosin; Treatment Outcome; Urination Disorders | 2005 |
Efficacy and safety of two doses (10 and 15 mg) of alfuzosin or tamsulosin (0.4 mg) once daily for treating symptomatic benign prostatic hyperplasia.
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Male; Middle Aged; Prostatic Hyperplasia; Quinazolines; Single-Blind Method; Sulfonamides; Tamsulosin; Treatment Outcome; Urination Disorders | 2005 |
Prophylactic tamsulosin (Flomax) in patients undergoing prostate 125I brachytherapy for prostate carcinoma: final report of a double-blind placebo-controlled randomized study.
Topics: Adenocarcinoma; Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Analysis of Variance; Area Under Curve; Brachytherapy; Double-Blind Method; Humans; Iodine Radioisotopes; Male; Middle Aged; Prostatic Neoplasms; Sulfonamides; Tamsulosin; Urinary Retention; Urination Disorders | 2005 |
Tamsulosin in the treatment of LUTS/BPH: an Italian multicentre trial.
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Humans; Italy; Male; Middle Aged; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urination Disorders | 2005 |
Comparison of two alpha1-adrenoceptor antagonists, naftopidil and tamsulosin hydrochloride, in the treatment of lower urinary tract symptoms with benign prostatic hyperplasia: a randomized crossover study.
Topics: Adrenergic alpha-Antagonists; Aged; Cross-Over Studies; Humans; Male; Naphthalenes; Piperazines; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin; Treatment Outcome; Urination Disorders; Urodynamics | 2006 |
Crossover comparison study on the therapeutic effects of tamsulosin hydrochloride and naftopidil in lower urinary tract symptoms associated with benign prostatic hyperplasia.
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Cross-Over Studies; Drug Therapy, Combination; Humans; Male; Middle Aged; Naphthalenes; Piperazines; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome; Urination Disorders | 2007 |
Efficacy of tamsulosin in the treatment of lower urinary tract symptoms (LUTS) in women.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Double-Blind Method; Female; Humans; Middle Aged; Prospective Studies; Sulfonamides; Tamsulosin; Treatment Outcome; Urination Disorders | 2007 |
The effects of dutasteride, tamsulosin and combination therapy on lower urinary tract symptoms in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the CombAT study.
Topics: Adrenergic alpha-Antagonists; Aged; Azasteroids; Double-Blind Method; Drug Therapy, Combination; Dutasteride; Enzyme Inhibitors; Follow-Up Studies; Humans; Male; Middle Aged; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Time Factors; Treatment Outcome; Urination Disorders | 2008 |
Effect of tamsulosin in preventing ureteral stent-related morbidity: a prospective study.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Female; Humans; Male; Middle Aged; Prospective Studies; Quality of Life; Stents; Sulfonamides; Tamsulosin; Ureter; Ureteroscopy; Urination Disorders | 2008 |
Transition zone ratio and prostate-specific antigen density as predictors of the response of benign prostatic hypertrophy to alpha blocker and anti-androgen therapy.
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Allylestrenol; Androgen Antagonists; Forecasting; Humans; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome; Urination Disorders; Urodynamics | 1997 |
[The efficacy and safety of terazosin and tamsulosin in patients with urinary disturbance accompanying prostatic hypertrophy].
Topics: Adrenergic alpha-Antagonists; Aged; Humans; Hyperlipidemias; Hypertension; Male; Middle Aged; Prazosin; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urination Disorders | 2001 |
Our experience with the treatment of benign prostatic hyperplasia (BPH) with tamsulosin.
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Humans; Male; Middle Aged; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urination Disorders | 2001 |
Tamsulosin as an effective treatment for reboxetine-associated urinary hesitancy.
Topics: Adrenergic alpha-Antagonists; Adult; Antidepressive Agents; Humans; Male; Middle Aged; Morpholines; Reboxetine; Severity of Illness Index; Sulfonamides; Tamsulosin; Urination Disorders | 2001 |
[Clinical evaluation of the effect of tamsulosin hydrochloride and cernitin pollen extract on urinary disturbance associated with benign prostatic hyperplasia in a multicentered study].
Topics: Adrenergic alpha-Antagonists; Aged; Drug Administration Schedule; Drug Therapy, Combination; Humans; Male; Middle Aged; Plant Extracts; Prostatic Hyperplasia; Secale; Sulfonamides; Tamsulosin; Urination Disorders | 2002 |
30 other study(ies) available for tamsulosin and Urination Disorders
Article | Year |
---|---|
Male lower urinary tract symptoms: a riddle waiting to be solved.
Topics: Adrenergic alpha-1 Receptor Antagonists; Humans; Lower Urinary Tract Symptoms; Male; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Sulfonamides; Tamsulosin; Tetrahydroisoquinolines; Urinary Bladder; Urination Disorders; Urological Agents | 2013 |
Reply from authors re: Apostolos Apostolidis. Male lower urinary tract symptoms: a riddle waiting to be solved. Eur Urol 2013;64:408-10: a rationale for combination antimuscarinic-α-blocker therapy for male lower urinary tract symptoms.
Topics: Adrenergic alpha-1 Receptor Antagonists; Humans; Lower Urinary Tract Symptoms; Male; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Sulfonamides; Tamsulosin; Tetrahydroisoquinolines; Urinary Bladder; Urination Disorders; Urological Agents | 2013 |
How many drugs for LUTS due to BPH are too many?
Topics: Adrenergic alpha-Antagonists; Benzhydryl Compounds; Cresols; Doxazosin; Drug Therapy, Combination; Enzyme Inhibitors; Erectile Dysfunction; Finasteride; Humans; Imidazoles; Male; Muscarinic Antagonists; Phenylpropanolamine; Piperazines; Prostatic Hyperplasia; Sulfonamides; Sulfones; Tamsulosin; Tolterodine Tartrate; Triazines; Urination Disorders; Vardenafil Dihydrochloride | 2008 |
Effect of tamsulosin on systemic blood pressure and nonneurogenic dysfunctional voiding in children.
Topics: Adolescent; Adrenergic alpha-Antagonists; Blood Pressure; Blood Pressure Determination; Child; Child, Preschool; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Probability; Retrospective Studies; Risk Assessment; Severity of Illness Index; Sulfonamides; Tamsulosin; Treatment Outcome; Urinary Retention; Urinary Tract Infections; Urination Disorders; Urodynamics | 2009 |
Re: Effect of tamsulosin on systemic blood pressure and nonneurogenic dysfunctional voiding in children: B. A. Vanderbrink, J. Gitlin, S. Toro and L. S. Palmer J Urol 2009; 181: 817-822.
Topics: Adrenergic alpha-Antagonists; Blood Pressure; Child; Humans; Sulfonamides; Tamsulosin; Urination Disorders | 2009 |
Primary bladder neck dysfunction in children and adolescents III: results of long-term alpha-blocker therapy.
Topics: Adolescent; Adrenergic alpha-Antagonists; Child; Child, Preschool; Female; Humans; Male; Prazosin; Sulfonamides; Tamsulosin; Time Factors; Urinary Bladder Neck Obstruction; Urination Disorders | 2010 |
[Clinical effects of increase in the loading dose of tamsulosin (from 0.2 mg to 0.3 mg) on urinary disturbance associated with benign prostate hyperplasia].
Topics: Adrenergic alpha-Antagonists; Aged; Humans; Male; Patient Satisfaction; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin; Urination Disorders | 2010 |
Editorial comment to short-term effects of crossover treatment with silodosin and tamsulosin hydrochloride for lower urinary tract symptoms associated with benign prostatic hyperplasia.
Topics: Adrenergic alpha-Antagonists; Humans; Indoles; Male; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urination Disorders | 2010 |
An older adult man who is unable to sleep: advocating self-care in home healthcare.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Home Care Services; Home Nursing; Humans; Male; Prostatic Hyperplasia; Self Care; Sleep Deprivation; Sulfonamides; Tamsulosin; Transurethral Resection of Prostate; Urination Disorders | 2011 |
[Role of alpha antagonists in uncoordinated micturition syndrome in childhood].
Topics: Adrenergic alpha-1 Receptor Antagonists; Child; Child, Preschool; Doxazosin; Female; Humans; Male; Retrospective Studies; Sulfonamides; Syndrome; Tamsulosin; Urination Disorders | 2010 |
Painful ejaculation and urinary hesitancy in association with antidepressant therapy: relief with tamsulosin.
Topics: Adrenergic alpha-Antagonists; Adult; Antidepressive Agents; Ejaculation; Humans; Male; Middle Aged; Morpholines; Pain; Reboxetine; Sulfonamides; Tamsulosin; Urination Disorders | 2002 |
[Correction of urination disorders caused by benign prostatic hyperplasia in cardiac surgery].
Topics: Adrenergic alpha-Antagonists; Coronary Artery Bypass; Humans; Male; Middle Aged; Postoperative Complications; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urination Disorders | 2003 |
Nocturia and benign prostatic hyperplasia.
Topics: Adrenergic alpha-Antagonists; Age Factors; Aged; Humans; Male; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Transurethral Resection of Prostate; Treatment Outcome; Urination Disorders; Urodynamics | 2003 |
[Generally effective for unstable bladder? Tamsulosin: application not limited to benign prostatic hyperplasia].
Topics: Adrenergic alpha-Antagonists; Aged; Female; Humans; Male; Middle Aged; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome; Urinary Bladder Neck Obstruction; Urination Disorders; Urodynamics | 2003 |
Voiding impairment after prostate biopsy: does tamsulosin treatment before biopsy decrease this morbidity?
Topics: Adrenergic alpha-Antagonists; Aged; Biopsy, Needle; Follow-Up Studies; Humans; Male; Middle Aged; Premedication; Prospective Studies; Prostate; Sulfonamides; Tamsulosin; Treatment Outcome; Ultrasonography, Interventional; Urinary Retention; Urination Disorders; Urodynamics | 2003 |
Herbal and vitamin supplement use in a prostate cancer screening population.
Topics: Adenocarcinoma; Adrenergic alpha-Antagonists; Adult; Aged; Colorado; Complementary Therapies; Dietary Supplements; Doxazosin; Drug Utilization; Family; Finasteride; Health Surveys; Humans; Male; Mass Screening; Middle Aged; Penile Erection; Phytotherapy; Plant Preparations; Prazosin; Prostatic Hyperplasia; Prostatic Neoplasms; Self Medication; Socioeconomic Factors; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Urination Disorders; Vitamins | 2004 |
Eliciting preferences for drug treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Azasteroids; Doxazosin; Dutasteride; Humans; Male; Middle Aged; Patient Satisfaction; Prostatic Hyperplasia; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Urination Disorders | 2004 |
Primary bladder neck dysfunction in children and adolescents II: results of treatment with alpha-adrenergic antagonists.
Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Child; Child, Preschool; Doxazosin; Electromyography; Female; Humans; Male; Sulfonamides; Tamsulosin; Urinary Bladder Neck Obstruction; Urination Disorders; Urodynamics | 2005 |
A comparison of four different alpha1-blockers in benign prostatic hyperplasia patients with and without diabetes.
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Cohort Studies; Diabetes Mellitus; Doxazosin; Follow-Up Studies; Humans; Male; Middle Aged; Prazosin; Probability; Prostatic Hyperplasia; Quinazolines; Reference Values; Retrospective Studies; Risk Assessment; Severity of Illness Index; Sulfonamides; Tamsulosin; Treatment Outcome; Urination Disorders; Urodynamics | 2004 |
Recovery of abnormal ejaculation by intermittent tamsulosin treatment.
Topics: Adrenergic alpha-Antagonists; Ejaculation; Humans; Male; Middle Aged; Prospective Studies; Sexual Dysfunction, Physiological; Sulfonamides; Tamsulosin; Urination Disorders | 2006 |
Discontinuation of tamsulosin treatment in men with lower urinary tract symptoms: a pilot study.
Topics: Adrenergic alpha-Antagonists; Aged; Humans; Male; Pilot Projects; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urination Disorders | 2006 |
Nocturnal polyuria in patients with lower urinary tract symptoms and response to alpha-blocker therapy.
Topics: Adrenergic alpha-Antagonists; Humans; Male; Middle Aged; Polyuria; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urination Disorders | 2006 |
[What does "intraoperative floppy iris" syndrome mean for urologists?].
Topics: Adrenergic alpha-Antagonists; Cataract Extraction; Humans; Iris Diseases; Sulfonamides; Tamsulosin; Urination Disorders | 2006 |
Zolpidem pharmacotherapy combined with alpha-blocker therapy for nocturia unresponsive to alpha-blocker monotherapy in men with lower urinary tract symptoms: a preliminary study.
Topics: Adrenergic alpha-Antagonists; Aged; Dose-Response Relationship, Drug; Humans; Male; Middle Aged; Prazosin; Prospective Studies; Prostatic Hyperplasia; Pyridines; Quality of Life; Statistics, Nonparametric; Sulfonamides; Tamsulosin; Treatment Outcome; Urination Disorders; Urodynamics; Zolpidem | 2007 |
Do alpha1-adrenoceptor antagonists improve lower urinary tract symptoms by reducing bladder outlet resistance?
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Humans; Male; Middle Aged; Muscle, Smooth; Prostate; Prostatic Hyperplasia; Retrospective Studies; Sulfonamides; Tamsulosin; Treatment Outcome; Urinary Bladder Neck Obstruction; Urination Disorders; Urodynamics | 2008 |
[Using of alpha1-adrenoreceptor blockers in urologic practice].
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Doxazosin; Humans; Middle Aged; Sulfonamides; Tamsulosin; Treatment Outcome; Urination Disorders; Urodynamics | 2007 |
[Some problems for dosage form based on questionnaire surveying compliance in patients taking tamsulosin hydrochloride].
Topics: Aged; Aged, 80 and over; Dosage Forms; Humans; Male; Patient Compliance; Prostatic Hyperplasia; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Urination Disorders | 2008 |
Temporary intraurethral prostatic bridge-catheter compared with neoadjuvant and adjuvant alpha-blockade to improve early results of high-energy transurethral microwave thermotherapy.
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Combined Modality Therapy; Diathermy; Humans; Male; Microwaves; Middle Aged; Prostatic Hyperplasia; Quality of Life; Retrospective Studies; Sulfonamides; Tamsulosin; Urethra; Urinary Catheterization; Urination Disorders; Urodynamics | 1999 |
By the way, doctor... I'm 78 and have more and more difficulty urinating. I get up three times a night - sometimes more - to go to the bathroom and it takes me a while to start urinating and even longer to stop. I know that this is probably a prostate pro
Topics: Adrenergic alpha-Antagonists; Aged; Finasteride; Humans; Male; Prazosin; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urination Disorders | 1999 |
Long-term use of tamsulosin to treat lower urinary tract symptoms/benign prostatic hyperplasia.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Aged; Aged, 80 and over; Double-Blind Method; Follow-Up Studies; Humans; Male; Middle Aged; Prostatic Hyperplasia; Severity of Illness Index; Sulfonamides; Tamsulosin; Time Factors; Urination Disorders; Urodynamics | 2001 |